21 news items
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LFCR
22 May 24
to the Company's previously-announced offer letter with Mr. Josephs, and as a material inducement to Mr. Josephs joining Lifecore as President and Chief
Lifecore Biomedical Completes Incremental Liquidity Initiatives
LFCR
16 May 24
. All forward-looking statements involve certain risks and uncertainties that could cause actual results to differ materially, including such factors
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC
LFCR
15 May 24
(NASDAQ:LFCR, LNDC))) resulting from allegations that Lifecore Biomedical may have issued materially misleading business
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
LFCR
13 May 24
allegations that Lifecore Biomedical may have issued materially misleading business information to the investing public
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC
LFCR
11 May 24
(NASDAQ:LFCR, LNDC))) resulting from allegations that Lifecore Biomedical may have issued materially misleading business information
74flv235o2jz97x7rmlx5228zevcekeg8
LFCR
7 May 24
(NASDAQ:LFCR, LNDC))) resulting from allegations that Lifecore Biomedical may have issued materially misleading business
e1uroeerkzbgx1eaf5yuv6vgc5tub71f0v0z
LFCR
5 May 24
allegations that Lifecore Biomedical may have issued materially misleading business information to the investing public
t9r1 fpjsrg65q5vwrilib3bohn9rqu4rvn4rw8yt7c2dtm5k5mrdu
LFCR
4 May 24
(NASDAQ:LFCR, LNDC))) resulting from allegations that Lifecore Biomedical may have issued materially misleading business information
tsj1bryg01jsxek2at 0rtfz71lq71h5048qc
LFCR
30 Apr 24
(NASDAQ:LFCR, LNDC))) resulting from allegations that Lifecore Biomedical may have issued materially misleading business
zeb5zdwyuj64hf86vl9 j4md1xlyc5ze6zst79wcgtyrl
LFCR
29 Apr 24
have issued materially misleading business information to the investing public
yrvycyr007g3y6vl
LFCR
25 Apr 24
(NASDAQ:LFCR, LNDC))) resulting from allegations that Lifecore Biomedical may have issued materially misleading business
mqhdqiq6eafnl12vjw1ppchx00mzoqgnfkxswa6gdwpm nbf
LFCR
20 Apr 24
(NASDAQ:LFCR, LNDC))) resulting from allegations that Lifecore Biomedical may have issued materially misleading business
4xa uxc797h6cnve03tpoh11vz5u5z60bdbke1i4b0c1t
LFCR
19 Apr 24
allegations that Lifecore Biomedical may have issued materially misleading business information to the investing public
c9v16gz
LFCR
19 Apr 24
and uncertainties that could cause actual results to differ materially, including such factors among others, as the Company's ability to respond
70vi6uph1v3pfyrufulzhnee
LFCR
15 Apr 24
(NASDAQ:LFCR, LNDC))) resulting from allegations that Lifecore Biomedical may have issued materially misleading business
nvo3tumsns67fxkns7qm8a7jj l2pa4qah9a5ewlb5
LFCR
12 Apr 24
allegations that Lifecore Biomedical may have issued materially misleading business information to the investing public
9f7ifkszsc98jzlm av
LFCR
11 Apr 24
materially misleading business information to the investing public.
SO
ly9sr9l94lf3fjpyx9gd6ketpg
LFCR
1 Apr 24
differ materially from these preliminary estimates, including as a result of audit adjustments and other developments that may arise between now
miq6d7x6j8d18m6dgb
LFCR
26 Mar 24
results to differ materially, including such factors among others, as the outcome of any evaluation of the Company's strategic alternatives or any
jlicpcdythlbflu0pdwoq
LFCR
20 Mar 24
by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors' losses and whether they may